Company / R&D Expense
SkinHealth Systems Inc. R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$10.1M
FY2025
5-year range
$3.4M / $10.1M
FY2021-FY2025
Trend
+19.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 3 consecutive years, from $3M in FY2022 to $10M in FY2025.
Based on SEC 10-K filings.
$10M in FY2025 with a 3-year CAGR of +43.6%.
Improved from $8M to $10M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +43.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- SkinHealth Systems Inc.'s r&d expense has grown for 3 consecutive years.
- 3-year CAGR of +43.6%, indicating consistent growth.
- In FY2025, r&d expense increased 19.6% year-over-year.
- Lowest r&d expense in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.1M | +19.6% |
| FY2024 | $8.4M | +3.0% |
| FY2023 | $8.2M | +140.4% |
| FY2022 | $3.4M | -26.1% |
| FY2021 | $4.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026